Is a flavonoid-rich diet with steamer cooking safe during calcineurin inhibitors therapy?

Journal of Clinical Pharmacy and Therapeutics

Volumn 39, Issue 5, 2014, Pages 471-474

  Peluso, I ^a   Palmery, M ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

calcineurin inhibitors; flavonoids; food drug interactions; steamer

Indexed keywords

CALCINEURIN INHIBITOR; FLAVONOID;

CITRUS FRUIT; COOKING; DRUG SAFETY; FOOD INTAKE; GENETIC POLYMORPHISM; GRAPE JUICE; HUMAN; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; TEA; VEGETABLE; DIET; FOOD DRUG INTERACTION; METABOLISM;

CALCINEURIN INHIBITORS; COOKING; DIET; FLAVONOIDS; FOOD-DRUG INTERACTIONS; HUMANS;

EID: 84906934987     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/jcpt.12186     Document Type: Review

References (33)

1. Storb R, Antin JH, Cutler C,. Should methotrexate plus calcineurin inhibitors be considered standard of care for prophylaxis of acute graft-versus-host disease? Biol Blood Marrow Transplant, 2010; 16 (Suppl 1): S18-S27.
2. Shibolet O, Regushevskaya E, Brezis M, Soares-Weiser K,. Cyclosporine A for induction of remission in severe ulcerative colitis. Cochrane Database Syst Rev, 2005; 1: CD004277.
3. Launay-Vacher V, Izzedine H, Deray G,. Statins' dosage in patients with renal failure and cyclosporine drug-drug interactions in transplant recipient patients. Int J Cardiol, 2005; 101: 9-17.
4. Kuypers DR,. Immunotherapy in elderly transplant recipients: a guide to clinically significant drug interactions. Drugs Aging, 2009; 26: 715-737.
5. Laryea M, Watt KD, Molinari M, et al,. Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events. Liver Transpl, 2007; 13: 1109-1114.
6. Mathis AS, Davé N, Knipp GT, Friedman GS,. Drug-related dyslipidemia after renal transplantation. Am J Health Syst Pharm, 2004; 61: 565-585.
7. Watt KD, Charlton MR,. Metabolic syndrome and liver transplantation: a review and guide to management. J Hepatol, 2010; 53: 199-206.
8. Won CS, Oberlies NH, Paine MF,. Mechanisms underlying food-drug interactions: inhibition of intestinal metabolism and transport. Pharmacol Ther, 2012; 136: 186-201.
9. Boullata JI,. Drug and nutrition interactions: not just food for thought. J Clin Pharm Ther, 2013; 38: 269-271.
10. Pauwels EK, Pauwels EK,. The protective effect of the Mediterranean diet: focus on cancer and cardiovascular risk. Med Princ Pract, 2011; 20: 103-111.
11. Calder PC, Ahluwalia N, Brouns F, et al,. Dietary factors and low-grade inflammation in relation to overweight and obesity. Br J Nutr, 2011; 106 (Suppl 3): S5-S78.
12. Pérez-Jiménez J, Neveu V, Vos F, Scalbert A,. Systematic analysis of the content of 502 polyphenols in 452 foods and beverages: an application of the phenol-explorer database. J Agric Food Chem, 2010; 58: 4959-4969.
13. Del Rio D, Rodriguez-Mateos A, Spencer JP, Tognolini M, Borges G, Crozier A,. Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid Redox Signal, 2013; 18: 1818-1892.
14. McCullough ML, Peterson JJ, Patel R, Jacques PF, Shah R, Dwyer JT,. Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults. Am J Clin Nutr, 2012; 95: 454-464.
15. Wedick NM, Pan A, Cassidy A, et al,. Dietary flavonoid intakes and risk of type 2 diabetes in US men and women. Am J Clin Nutr, 2012; 95: 925-933.
16. Peluso I, Raguzzini A, Serafini M,. Effect of flavonoids on circulating levels of TNF-α and IL-6 in humans: a systematic review and meta-analysis. Mol Nutr Food Res, 2013; 57: 784-801.
17. Egashira K, Fukuda E, Onga T, et al,. Pomelo-induced increase in the blood level of tacrolimus in a renal transplant patient. Transplantation, 2003; 75: 1057.
18. Fukatsu S, Fukudo M, Masuda S, et al,. Delayed effect of grapefruit juice on pharmacokinetics and pharmacodynamics of tacrolimus in a living-donor liver transplant recipient. Drug Metab Pharmacokinet, 2006; 21: 122-125.
19. Grenier J, Fradette C, Morelli G, Merritt GJ, Vranderick M, Ducharme MP,. Pomelo juice, but not cranberry juice, affects the pharmacokinetics of cyclosporine in humans. Clin Pharmacol Ther, 2006; 79: 255-262.
20. Johnston PE, Milstone A,. Probable interaction of bergamottin and cyclosporine in a lung transplant recipient. Transplantation, 2005; 79: 746.
21. Peynaud D, Charpiat B, Vial T, Gallavardin M, Ducerf C,. Tacrolimus severe overdosage after intake of masked grapefruit in orange marmalade. Eur J Clin Pharmacol, 2007; 63: 721-722.
22. Schwarz UI, Johnston PE, Bailey DG, Kim RB, Mayo G, Milstone A,. Impact of citrus soft drinks relative to grapefruit juice on cyclosporin disposition. Br J Clin Pharmacol, 2006; 62: 485-491.
23. Paine MF, Widmer WW, Hart HL, et al,. A furanocoumarin-free grapefruit juice establishes furanocoumarins as the mediators of the grapefruit juice-felodipine interaction. Am J Clin Nutr, 2006; 83: 1097-1105.
24. Ieiri I, Takane H, Otsubo K,. The MDR1 (ABCB1) gene polymorphism and its clinical implications. Clin Pharmacokinet, 2004; 43: 553-576.
25. Staatz CE, Goodman LK, Tett SE,. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: part I. Clin Pharmacokinet, 2010; 49: 141-175.
26. Ingelman-Sundberg M, Sim SC, Gomez A, Rodriguez-Antona C,. Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects. Pharmacol Ther, 2007; 116: 496-526.
27. Vischini G, Niscola P, Stefoni A, Farneti F,. Increased plasma levels of tacrolimus after ingestion of green tea. Am J Kidney Dis, 2011; 58: 329.
28. Jürgen Roth H, Wintergalen M,. Unusual high levels of cyclosporine in a female patient-the impact of lifestyle? Clin Lab, 2005; 51: 425-427.
29. van Boekel M, Fogliano V, Pellegrini N, et al,. A review on the beneficial aspects of food processing. Mol Nutr Food Res, 2010; 54: 1215-1247.
30. Latté KP, Appel KE, Lampen A,. Health benefits and possible risks of broccoli-an overview. Food Chem Toxicol, 2011; 49: 3287-3309.
31. Cermak R,. Effect of dietary flavonoids on pathways involved in drug metabolism. Expert Opin Drug Metab Toxicol, 2008; 4: 17-35.
32. Moon YJ, Wang X, Morris ME,. Dietary flavonoids: effects on xenobiotic and carcinogen metabolism. Toxicol In Vitro, 2006; 20: 187-210.
33. Dong H, Lin W, Wu J, Chen T,. Flavonoids activate pregnane x receptor-mediated CYP3A4 gene expression by inhibiting cyclin-dependent kinases in HepG2 liver carcinoma cells. BMC Biochem, 2010; 11: 23.